Posted on 12/10/2003 9:36:05 AM PST by trajanus_red
Stealth Merger: Drug Companies and Government Medical Research Some of the National Institutes of Health's top scientists are also collecting paychecks and stock options from biomedical firms. Increasingly, such deals are kept secret. Case Studies JOHN I. GALLIN : A Clinic Chief's Desire to 'Learn About Industry' RONALD N. GERMAIN: A Federal Lab Leader Who Made $1.4 Million on the Side JEFFREY SCHLOM: A Cancer Expert Who Aided Studies Using a Drug Wanted by a Client RICHARD C. EASTMAN: A Federal Researcher Who Defended a Client's Lethal Drug JEFFREY M. TRENT: A Government Accolade From a Paid Consultant • What the Stealth Merger: Drug Companies and Government Medical Research Some of the National Institutes of Health's top scientists are also collecting paychecks and stock options from biomedical firms. Increasingly, such deals are kept secret.
Case Studies
JOHN I. GALLIN : A Clinic Chief's Desire to 'Learn About Industry'
RONALD N. GERMAIN: A Federal Lab Leader Who Made $1.4 Million on the Side
JEFFREY SCHLOM: A Cancer Expert Who Aided Studies Using a Drug Wanted by a Client
RICHARD C. EASTMAN: A Federal Researcher Who Defended a Client's Lethal Drug
JEFFREY M. TRENT: A Government Accolade From a Paid Consultant
• What the Law Says
• Stealth Mergers
Photos
'SUBJECT NO. 4': Jamie Ann Jackson
Patient (David Kennedy / For The Times) December 6, 2003 Quote
"I have always received official permission to perform ... consultations and have performed [them] outside of my normal NIH work schedule and according to strict government guidelines and rules." -- DR. STEPHEN I. KATZ, director of the NIH's arthritis institute Document
Opening the door December 6, 2003 (Acrobat file) Graphics
A federal partner December 6, 2003
December 6, 2003
December 6, 2003 Related Stories
About This Report December 7, 2003 Times Headlines
3 Indicted in R.I. Club Blaze
DNA Tests Clear Pennsylvania Capital Inmate After 21 Years
Relief Marks End of Janklow Trial
Debate Keys on Gore, Dean
Dean Basks in Gore's Support
more >
CONFLICT OF INTEREST
MEDICAL RESEARCH
NATIONAL INSTITUTES OF HEALTH
NATIONAL INSTITUTES OF HEALTH CONFLICT OF INTEREST
ETHICS
By David Willman, Times Staff Writer
BETHESDA, Md. — "Subject No. 4" died at 1:44 a.m. on June 14, 1999, in the immense federal research clinic of the National Institutes of Health.
The cause of death was clear: a complication from an experimental treatment for kidney inflammation using a drug made by a German company, Schering AG.
Among the first to be notified was Dr. Stephen I. Katz, the senior NIH official whose institute conducted the study.
Unbeknown to the participants, Katz also was a paid consultant to Schering AG.
Katz and his institute staff could have responded to the death by stopping the study immediately....
(Excerpt) Read more at latimes.com ...
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.